By Mill Chart
Last update: Apr 3, 2024
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Ticker | Change | Comment |
---|---|---|
UCAR | 10.0K% | U POWER LTD's (NASDAQ:UCAR) shares rose 10.0K% to $6.1 during Wednesday's session. In the last 3 months the share price dropped with 57.12%. |
RENT | 2.0K% | RENT THE RUNWAY INC-A's (NASDAQ:RENT) stock price is advancing with 2.0K% to a price of $6.44. The stock is trading 29.98% lower than 3 months ago. |
KTRA | 77.69% | Positive market sentiment drove KINTARA THERAPEUTICS INC's (NASDAQ:KTRA) stock price up by 77.69% to $0.18 during Wednesday's session. A press release (KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders) was released earlier today. |
EGOX | 51.15% | Investors celebrated as NEXT.E.GO NV (NASDAQ:EGOX) experienced a 51.15% rise in its shares, closing at $0.04 during Wednesday's session. The stock is trading 79.53% lower than a month ago. |
VNDA | 40.24% | With a 40.24% surge, VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) stock price reached $5.48 during Wednesday's session, signaling positive momentum. The stock is trading 43.09% lower than a year ago. |
SBFM | 32.72% | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) rose 32.72% to $0.11 during Wednesday's after hours session. In the last month the stock gained 82.41%. |
SWVL | 31.49% | SWVL HOLDINGS CORP (NASDAQ:SWVL) witnessed a notable 31.49% uptick in its shares, reaching $20.0 during Wednesday's session. The stock is trading 182.0% higher than a month ago. |
ORGN | 31.35% | ORIGIN MATERIALS INC (NASDAQ:ORGN) experienced a significant 31.35% increase, reaching $0.64 during Wednesday's session. Earlier today the company had a press release: Origin Materials Converts Wood Residue Feedstock into Sustainable Intermediates at Commercial-Scale Plant. |
COCH | 29.2% | ENVOY MEDICAL INC (NASDAQ:COCH) experienced a significant 29.2% increase, reaching $5.79 during Wednesday's session. A press release (Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024) was released earlier today. |
ACB | 28.5% | AURORA CANNABIS INC (NASDAQ:ACB) rose 28.5% to $6.44 during Wednesday's after hours session. In the last month the share price increased with 65.18%. |
Our top gainers page will show you the full list.
Ticker | Change | Comment |
---|---|---|
CASA | -80.58% | CASA SYSTEMS INC's (NASDAQ:CASA) stock price is declining with 80.58% to a price of $0.05. Earlier today the company had a press release: Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses. |
VIEW | -62.73% | VIEW INC's (NASDAQ:VIEW) stock price decreased by 62.73% to $0.41. A press release (View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company) was released yesterday. |
SINT | -44.01% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares fell 44.01% to $0.02 during Wednesday's session. In the last month the share price dropped with 69.84%. |
TCON | -39.08% | TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) stock price faced a 39.08% decline, reaching $0.25 during Wednesday's session. A press release (TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned) was released earlier today. |
MTNB | -37.14% | MATINAS BIOPHARMA HOLDINGS I's (NYSEARCA:MTNB) shares fell 37.14% to $0.22. In the last month the stock gained 30.06%. |
FGEN | -34.97% | There was a notable decline in FIBROGEN INC's (NASDAQ:FGEN) shares, as they dropped 34.97% to $1.4 during Wednesday's session. In the last 3 months the share price increased with 188.0%. |
JZXN | -34.65% | JIUZI HOLDINGS INC's (NASDAQ:JZXN) stock price faced a 34.65% decline, reaching $2.45 during Wednesday's session. In the last month the stock gained 205.0%. |
ANGH | -26.66% | There was a notable decline in ANGHAMI INC's (NASDAQ:ANGH) shares, as they dropped 26.66% to $1.32 during Wednesday's session. In the last month the share price increased with 93.03%. |
BCAN | -24.21% | The market experienced a downward movement in BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) stock price, closing at $0.95 with a 24.21% decrease during Wednesday's session. A press release (Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023) was released yesterday. |
VLCN | -23.12% | VOLCON INC's (NASDAQ:VLCN) stock price is declining with 23.12% to a price of $0.34. The stock is trading 58.71% lower than a month ago. |
Our top losers page will show you the full list.
FIBROGEN INC
NASDAQ:FGEN (5/2/2024, 1:33:04 PM)
1.2
+0.03 (+2.56%)
SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial results on Monday, May 6 after...
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that clinical data from the dose escalation portion of...
FG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at ≥ 1.2 mg/kg in heavily pre-treated,...
SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will...
Selling these three NASDAQ stocks might be the best option now, as they continue to show potential issues and continued weakness.
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executive leader...
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!
AstraZeneca returns rights to FibroGen for roxadustat, a drug used for treating anemia related to chronic kidney disease. Read more here.
• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246...
The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place FibroGen to explore licensing opportunities for Roxadustat SAN FRANCISCO,...